Endocrine Therapy Before Surgery Results in Different Outcomes in Black vs. White Women With Breast Cancer, City of Hope-Led Study Finds
Black women are four times more likely than white women to die of hormone receptor-positive breast cancer.
- Black women are four times more likely than white women to die of hormone receptor-positive breast cancer.
- While neoadjuvant endocrine therapy appeared to benefit Black women with Stage 1 and 2 breast cancer, our findings suggest that it was not beneficial in Black women with more advanced tumors.
- To examine health outcome differences between Black and white women, Jones and colleagues analyzed 3,521 white women and 365 Black women with Stage 1 through 3 hormone receptor-positive breast cancer from the National Cancer Database.
- Little is known about the contribution of endocrine therapy resistance to the mortality disparity seen in Black women.